| Rajnish Wellness Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 541601 |
NSE Symbol : - |
P/E(TTM) : 0.00 |
|
ISIN Demat : INE685Z01033 |
Div & Yield% : 0.00 |
EPS(TTM) : 0.00 |
|
Book Value(₹) : 1.07 |
Market Cap(₹Cr) : 70.06 |
Face Value(₹) : 1.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 12.00 | 4.56 | 5.77 | 9.06 | 17.42 | 16.30 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 12.00 | 4.56 | 5.77 | 9.06 | 17.42 | 16.30 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.31 | 0.12 | 0.16 | 0.01 | 0.00 | 0.35 |
| Total Income | 12.32 | 4.67 | 5.93 | 9.08 | 17.42 | 16.65 |
| Total Expenditure | 12.22 | 4.38 | 6.39 | 8.93 | 16.94 | 16.29 |
| PBIDT | 0.09 | 0.29 | -0.45 | 0.15 | 0.48 | 0.36 |
| Interest | 0.00 | 0.00 | 0.00 | 0.04 | 0.10 | 0.13 |
| PBDT | 0.09 | 0.29 | -0.45 | 0.11 | 0.38 | 0.23 |
| Depreciation | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.00 |
| Tax | 0.02 | 0.08 | 0.00 | 0.02 | 0.09 | 0.06 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reported Profit After Tax | 0.06 | 0.22 | -0.46 | 0.07 | 0.28 | 0.17 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 0.06 | 0.22 | -0.46 | 0.07 | 0.28 | 0.17 |
| EPS (Unit Curr.) | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 |
| EPS (Adj) (Unit Curr.) | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 |
| Calculated EPS (Unit Curr.) | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 |
| Calculated EPS (Adj) (Unit Curr.) | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 |
| Calculated EPS (Ann.) (Unit Curr.) | 0.00 | 0.01 | -0.02 | 0.00 | 0.01 | 0.01 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 0.00 | 0.01 | -0.02 | 0.00 | 0.01 | 0.01 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 101.53 | 76.85 | 76.85 | 76.85 | 76.85 | 76.85 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 0.75 | 6.36 | -7.80 | 1.66 | 2.76 | 2.21 |
| PBDTM(%) | 0.75 | 6.36 | -7.80 | 1.21 | 2.18 | 1.41 |
| PATM(%) | 0.50 | 4.82 | -7.97 | 0.77 | 1.61 | 1.04 |